Axiom Laboratories, a subsidiary of dietary supplement contract manufacturer Axiom Nutraceuticals, has purchased the commercial nutritional supplement manufacturing facility previously owned by Metaugus Inc. This acquisition allows Axiom Nutraceuticals increased manufacturing capabilities to better serve a wide range of supplement distributors, medical practitioners, ecommerce providers, retail stores, and other businesses in the nutritional health and wellness industry.
With approximately 100,000 square feet of manufacturing space, Axiom Nutraceuticals boasts daily production capacities of 10 million capsules, 150,000 tablets, 75,000 units of powdered product, and 50,000 liquid product units. The facility has been updated to meet all current FDA regulations, including new individualized state-of-the-art capsule production rooms with centralized air ventilation systems to prevent cross contamination of products during the manufacturing process.
Axiom’s cGMP facility allows the unique advantage of both large and small unit runs, with advanced equipment including 4 high speed automatic encapsulation machines, as well as 14 semiautomatic machines. The supplement manufacturing plant can also produce Halaal and Kosher dietary supplements upon request. The laboratory personnel includes 4 PhD’s, experienced chemists, and medical advisors to insure that product development is both innovative and safe for consumers.
“The acquisition of this research and manufacturing facility allows us the ability to provide supplement distributors a wide variety of highly innovative dietary supplements,” states James VanBrocklin, CEO of Axiom Nutraceuticals. “Unlike other contract manufacturers, we are vertically integrated and offer distributors a complete turnkey system to develop top-selling, custom-labeled nutritional supplements that meet the needs of their unique audience.”